207 related articles for article (PubMed ID: 32824972)
1. Normoxic Tumour Extracellular Vesicles Modulate the Response of Hypoxic Cancer and Stromal Cells to Doxorubicin In Vitro.
Patras L; Fens MHAM; Vader P; Barendrecht A; Sesarman A; Banciu M; Schiffelers R
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32824972
[TBL] [Abstract][Full Text] [Related]
2. Targeting acute hypoxic cancer cells by doxorubicin-immunoliposomes directed by monoclonal antibodies specific to RON receptor tyrosine kinase.
Guin S; Ma Q; Padhye S; Zhou YQ; Yao HP; Wang MH
Cancer Chemother Pharmacol; 2011 May; 67(5):1073-83. PubMed ID: 20658288
[TBL] [Abstract][Full Text] [Related]
3. The effect of HIF-1α inhibition in breast cancer cells prior to doxorubicin treatment under conditions of normoxia and hypoxia.
Fourie C; du Plessis M; Mills J; Engelbrecht AM
Exp Cell Res; 2022 Oct; 419(2):113334. PubMed ID: 36044939
[TBL] [Abstract][Full Text] [Related]
4. Silymarin modulates doxorubicin-induced oxidative stress, Bcl-xL and p53 expression while preventing apoptotic and necrotic cell death in the liver.
Patel N; Joseph C; Corcoran GB; Ray SD
Toxicol Appl Pharmacol; 2010 Jun; 245(2):143-52. PubMed ID: 20144634
[TBL] [Abstract][Full Text] [Related]
5. Nitrite-derived nitric oxide reduces hypoxia-inducible factor 1α-mediated extracellular vesicle production by endothelial cells.
Burnley-Hall N; Willis G; Davis J; Rees DA; James PE
Nitric Oxide; 2017 Feb; 63():1-12. PubMed ID: 28017872
[TBL] [Abstract][Full Text] [Related]
6. Mad1 mediates hypoxia-induced doxorubicin resistance in colon cancer cells by inhibiting mitochondrial function.
Cho K; Shin HW; Kim YI; Cho CH; Chun YS; Kim TY; Park JW
Free Radic Biol Med; 2013 Jul; 60():201-10. PubMed ID: 23459071
[TBL] [Abstract][Full Text] [Related]
7. Anti-angiogenic and anti-inflammatory effects of long-circulating liposomes co-encapsulating curcumin and doxorubicin on C26 murine colon cancer cells.
Sesarman A; Tefas L; Sylvester B; Licarete E; Rauca V; Luput L; Patras L; Banciu M; Porfire A
Pharmacol Rep; 2018 Apr; 70(2):331-339. PubMed ID: 29477042
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia-Activated Prodrug Enabling Synchronous Chemotherapy and HIF-1α Downregulation for Tumor Treatment.
Luo X; Li A; Chi X; Lin Y; Liu X; Zhang L; Su X; Yin Z; Lin H; Gao J
Bioconjug Chem; 2021 May; 32(5):983-990. PubMed ID: 33847488
[TBL] [Abstract][Full Text] [Related]
9. Bifunctional liposomes reduce the chemotherapy resistance of doxorubicin induced by reactive oxygen species.
Xu L; Zhang Z; Ding Y; Wang L; Cheng Y; Meng L; Wu J; Yuan A; Hu Y; Zhu Y
Biomater Sci; 2019 Nov; 7(11):4782-4789. PubMed ID: 31524211
[TBL] [Abstract][Full Text] [Related]
10. Pyrrolidine dithiocarbamate reverses Bcl-xL-mediated apoptotic resistance to doxorubicin by inducing paraptosis.
Park SS; Lee DM; Lim JH; Lee D; Park SJ; Kim HM; Sohn S; Yoon G; Eom YW; Jeong SY; Choi EK; Choi KS
Carcinogenesis; 2018 Mar; 39(3):458-470. PubMed ID: 29329420
[TBL] [Abstract][Full Text] [Related]
11. Quercetin greatly improved therapeutic index of doxorubicin against 4T1 breast cancer by its opposing effects on HIF-1α in tumor and normal cells.
Du G; Lin H; Wang M; Zhang S; Wu X; Lu L; Ji L; Yu L
Cancer Chemother Pharmacol; 2010 Jan; 65(2):277-87. PubMed ID: 19466611
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia inducible factor-1α/B-cell lymphoma 2 signaling impacts radiosensitivity of H1299 non-small cell lung cancer cells in a normoxic environment.
Wang G; Xiao L; Wang F; Yang J; Yang L; Zhao Y; Jin W
Radiat Environ Biophys; 2019 Aug; 58(3):439-448. PubMed ID: 31203382
[TBL] [Abstract][Full Text] [Related]
13. Anterior gradient 2 is a binding stabilizer of hypoxia inducible factor-1α that enhances CoCl2 -induced doxorubicin resistance in breast cancer cells.
Li Z; Zhu Q; Hu L; Chen H; Wu Z; Li D
Cancer Sci; 2015 Aug; 106(8):1041-9. PubMed ID: 26079208
[TBL] [Abstract][Full Text] [Related]
14. Hypoxic tumor therapy by hemoglobin-mediated drug delivery and reversal of hypoxia-induced chemoresistance.
Yang J; Li W; Luo L; Jiang M; Zhu C; Qin B; Yin H; Yuan X; Yin X; Zhang J; Luo Z; Du Y; You J
Biomaterials; 2018 Nov; 182():145-156. PubMed ID: 30121013
[TBL] [Abstract][Full Text] [Related]
15. Decursin promotes HIF-1α proteasomal degradation and immune responses in hypoxic tumour microenvironment.
Ge Y; Yoon SH; Jang H; Jeong JH; Lee YM
Phytomedicine; 2020 Nov; 78():153318. PubMed ID: 32896707
[TBL] [Abstract][Full Text] [Related]
16. Extracellular Vesicles Derived from Hypoxic Colorectal Cancer Cells Confer Metastatic Phenotype to Non-metastatic Cancer Cells.
Endzeliņš E; Ābols A; Bušs A; Zandberga E; Palviainen M; Siljander P; Linē A
Anticancer Res; 2018 Sep; 38(9):5139-5147. PubMed ID: 30194161
[TBL] [Abstract][Full Text] [Related]
17. In vivo anti-tumor effect of PEG liposomal doxorubicin (DOX) in DOX-resistant tumor-bearing mice: Involvement of cytotoxic effect on vascular endothelial cells.
Ogawara K; Un K; Tanaka K; Higaki K; Kimura T
J Control Release; 2009 Jan; 133(1):4-10. PubMed ID: 18840484
[TBL] [Abstract][Full Text] [Related]
18. Imatinib Inhibits the Renewal and Tumorigenicity of CT-26 Colon Cancer Cells after Cytoreductive Treatment with Doxorubicin.
Przybyszewska M; Miłoszewska J; Kotlarz A; Swoboda P; Pyśniak K; Szczepek W; Kaczmarek Ł; Markowicz S
Arch Immunol Ther Exp (Warsz); 2017 Feb; 65(1):51-67. PubMed ID: 26956644
[TBL] [Abstract][Full Text] [Related]
19. A combined treatment TNF-alpha/doxorubicin alleviates the resistance of MCF-7/Adr cells to cytotoxic treatment.
Cao W; Ma SL; Tang J; Shi J; Lu Y
Biochim Biophys Acta; 2006 Feb; 1763(2):182-7. PubMed ID: 16483679
[TBL] [Abstract][Full Text] [Related]
20. An Akt/hypoxia-inducible factor-1alpha/platelet-derived growth factor-BB autocrine loop mediates hypoxia-induced chemoresistance in liver cancer cells and tumorigenic hepatic progenitor cells.
Lau CK; Yang ZF; Ho DW; Ng MN; Yeoh GC; Poon RT; Fan ST
Clin Cancer Res; 2009 May; 15(10):3462-71. PubMed ID: 19447872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]